Latest Financial Results News

Health and Plant Protein Group Limited (HPP) reported a reduced net loss of $528,000 for FY2025, following the receipt of final proceeds from its US divestment. The Board signals plans to return capital and pursue new corporate opportunities.

Spheria Emerging Companies Limited has reported a remarkable doubling of both revenue and profit for the fiscal year ending June 2025, alongside increased fully franked dividends.

AGL Energy has clarified that its FY25 underlying earnings aligned with market forecasts and published guidance, dismissing any material surprises in its financial results. The company also addressed statutory profit volatility and confirmed compliance with ASX disclosure rules.

Morphic Ethical Equities Fund Limited reported a strong turnaround in FY2025 with a $5.44 million net profit and portfolio returns surpassing its benchmark, while continuing aggressive share buybacks despite withholding dividends.

WAM Income Maximiser Limited has reported a profitable first half since its April 2025 IPO, declaring its inaugural fully franked monthly dividend and setting guidance for dividend growth. The company’s diversified portfolio of ASX300 equities and investment grade corporate debt has delivered promising returns, underpinning its income and capital growth objectives.

Nyrada Inc. reported a sharp 25% decline in revenues alongside a 248% surge in net losses for the fiscal year ending June 2025, signaling mounting financial pressures for the pharmaceutical developer.

Monash IVF Group reported a 5.6% rise in underlying EBITDA for FY25, navigating a declining Australian IVF market and operational challenges. The company sets a cautious FY26 NPAT guidance of $20-23 million while focusing on regaining market leadership and implementing safety reforms.

Monash IVF Group reported steady FY25 financial results with revenue and EBITDA growth, while managing clinical incidents and a CEO transition. The company outlines cautious FY26 guidance amid industry headwinds.

Cue Energy Resources reported a 10.4% increase in revenue to $54.8 million for FY2025, driven by stable production and higher gas prices, but net profit after tax halved to $6.32 million due to rising costs. The company declared a final dividend of 0.5 cents per share.

Monash IVF Group reported a 6.7% revenue increase to $271.9 million in FY25 but saw an 8.1% decline in underlying net profit after tax to $27.4 million, impacted by market softness and operational incidents. The company outlines cautious FY26 guidance amid ongoing sector headwinds.

Rural Funds Group reported FY25 results aligned with forecasts, showcasing steady distributions and a diversified agricultural portfolio. The group maintains solid gearing and advances key development projects while forecasting stable AFFO and distributions for FY26.

Rural Funds Group reported a 17% revenue increase for the year ended June 2025, but net profit and total comprehensive income sharply declined. The dividend reinvestment plan remains suspended, signaling cautious investor sentiment.